GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (NSE:PANACEABIO) » Definitions » Cyclically Adjusted Book per Share

Panacea Biotec (NSE:PANACEABIO) Cyclically Adjusted Book per Share : ₹135.87 (As of Mar. 2025)


View and export this data going back to 1996. Start your Free Trial

What is Panacea Biotec Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Panacea Biotec's adjusted book value per share for the three months ended in Mar. 2025 was ₹136.290. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹135.87 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2025-07-24), Panacea Biotec's current stock price is ₹432.20. Panacea Biotec's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₹135.87. Panacea Biotec's Cyclically Adjusted PB Ratio of today is 3.18.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Panacea Biotec was 4.02. The lowest was 2.05. And the median was 3.23.


Panacea Biotec Cyclically Adjusted Book per Share Historical Data

The historical data trend for Panacea Biotec's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Biotec Cyclically Adjusted Book per Share Chart

Panacea Biotec Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 135.87

Panacea Biotec Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 136.25 - 135.87

Competitive Comparison of Panacea Biotec's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Panacea Biotec's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panacea Biotec's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panacea Biotec's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Panacea Biotec's Cyclically Adjusted PB Ratio falls into.


;
;

Panacea Biotec Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Panacea Biotec's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=136.29/157.5517*157.5517
=136.290

Current CPI (Mar. 2025) = 157.5517.

Panacea Biotec Quarterly Data

Book Value per Share CPI Adj_Book
200703 87.976 48.581 285.310
200803 105.286 52.407 316.524
200903 92.475 56.615 257.347
201003 104.832 65.030 253.981
201103 97.072 70.768 216.112
201203 142.874 76.889 292.761
201303 102.152 85.687 187.826
201403 83.708 91.425 144.253
201503 76.944 97.163 124.766
201603 65.887 102.518 101.256
201703 58.068 105.196 86.968
201803 50.395 109.786 72.321
201806 0.000 111.317 0.000
201809 0.000 115.142 0.000
201812 0.000 115.142 0.000
201903 57.207 118.202 76.251
201906 0.000 120.880 0.000
201909 46.874 123.175 59.956
201912 0.000 126.235 0.000
202003 32.454 124.705 41.002
202006 0.000 127.000 0.000
202009 -22.099 130.118 -26.758
202012 0.000 130.889 0.000
202103 -37.337 131.771 -44.642
202106 0.000 134.084 0.000
202109 -55.320 135.847 -64.159
202112 0.000 138.161 0.000
202203 143.122 138.822 162.432
202206 0.000 142.347 0.000
202209 131.936 144.661 143.693
202212 0.000 145.763 0.000
202303 137.729 146.865 147.751
202306 0.000 150.280 0.000
202309 138.282 151.492 143.813
202312 0.000 152.924 0.000
202403 137.475 153.035 141.533
202406 0.000 155.789 0.000
202409 135.983 157.882 135.698
202412 0.000 158.323 0.000
202503 136.290 157.552 136.290

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Panacea Biotec  (NSE:PANACEABIO) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Panacea Biotec's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=432.20/135.87
=3.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Panacea Biotec was 4.02. The lowest was 2.05. And the median was 3.23.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Panacea Biotec Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Panacea Biotec's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacea Biotec Business Description

Industry
Traded in Other Exchanges
Address
Mathura Road, B-1 Extension/G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044
Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec Headlines

No Headlines